64 results
6-K
ASND
Ascendis Pharma A/S
2 May 24
Current report (foreign)
4:29pm
March 31, 2023. This increase was primarily due to higher employee costs, including the impact from commercial expansion, partly offset by lower … , and for further adjustment for changes to non-operating financial income and expenses, taxes and non-cash items of total €73.3 million, offset by increased
6-K
EX-99.1
ASND
Ascendis Pharma A/S
2 May 24
Ascendis Pharma Reports First Quarter 2024 Financial Results
4:22pm
inventories) and Oncology programs, partially offset by an increase in TransCon CNP costs.
Selling, general, and administrative (SG&A) expenses … commercial expansion, partly offset by lower external pre-launch and administrative expenses.
Total operating expenses for the first quarter of 2024
6-K
EX-99.2
ASND
Ascendis Pharma A/S
2 May 24
Notice to convene Annual General Meeting 2024
4:02pm
due to €32.4 million lower exchange rate gains, partly offset by €14.7 million gain on derivative liabilities compared to no gain on derivative … was primarily due to a gain on derivative liabilities in 2023 compared to a €15.5 million loss on derivative liabilities in 2022, partly offset by €13.4
6-K
EX-99.1
l8uwft z6y7
7 Feb 24
Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
4:05pm
6-K
34yu v98amvwm
7 Nov 23
Current report (foreign)
4:03pm
6-K
EX-99.1
0i0lcme870zkpqi
7 Nov 23
Ascendis Pharma Reports Third Quarter 2023 Financial Results
4:01pm
6-K
raesmpot
5 Sep 23
Current report (foreign)
4:14pm
6-K
EX-99.1
6iambzp1hv1q
5 Sep 23
Ascendis Pharma Reports Second Quarter 2023 Financial Results
4:09pm
6-K
EX-99.2
20ua7db94 g5s
2 May 23
Notice to convene Annual General Meeting 2023
4:02pm
6-K
fkyrpx3aucpo 1v3
27 Apr 23
Current report (foreign)
4:02pm
6-K
dern6ot
2 Nov 22
Current report (foreign)
4:31pm
6-K
ikietsbwl
10 Aug 22
Current report (foreign)
4:13pm
6-K
EX-99.2
ahxk dbaf
11 May 22
Current report (foreign)
4:06pm
6-K
EX-99.2
1b9co0snywmxu
2 May 22
Notice to convene Annual General Meeting 2022
6:25am
6-K
EX-99.2
a7h2 qouyse8y
10 Nov 21
Current report (foreign)
4:15pm
424B5
xnaag3jd0mb3xduzeo
2 Sep 21
Prospectus supplement for primary offering
4:36pm